Daily FNArena News - Small Caps

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Fantastic: An Opportunity In Furniture

Nov 21 2012

Fantastic Furniture’s competitive and vertically integrated business should flourish with any housing and sentiment rebound, according to Goldman Sachs.


Positive Tin Outlook Makes Kasbah A Buy

Nov 19 2012

OctaPhillip is positive on the longer-term outlook for tin prices and to reflect this upgrades its rating on junior play Kasbah Resources to Buy.


Grange Endures Tough September Quarter

Oct 26 2012

Grange Resources had a tough September quarter and the uncertainty of any selldown of the Southdown project sees brokers remain cautious on the stock.


Amex Resources Progresses With Iron Sands

Oct 23 2012

Amex resources is a small explorer on track for iron sands mine in Fiji. A robust feasibility study supports a 20-year mine life with low operating costs.


Fleetwood Not Unhitched

Oct 09 2012

Fleetwood is feeling the effects of reduced occupancy in one of its villages and RBS has become more cautious on the near-term, but not longer term, outlook.


FlexiGroup Attracts More Interest

Oct 05 2012

FlexiGroup has grabbed more broker attention with a robust outlook and high potential, despite the much-publicised difficulties in the retail and finance sectors.


Santos Boosts Central Petroleum

Oct 04 2012

A farm-in deal with Santos sees DJ Carmichael reiterate a positive view on Central Petroleum.


Moelis Continues To See Value In BigAir

Sep 26 2012

Share price gains over the past year prompted RBS Australia to downgrade to a Hold rating last month, but Moelis continues to rate junior telco BigAir as a Buy given a solid growth outlook.


Elk’s Production Growth Offers Attractive Entry

Sep 25 2012

Elk Petroleum offers an attractive production growth profile from Enhanced Oil Recovery operations in the US and DJ Carmichael initiates coverage with a Buy rating.


Bionomics Acquisition A Plus

Sep 24 2012

Bionomics has moved into the cancer stem cell field through a US acquisition and on the news Bell Potter reiterates its Buy rating for the stock.



Analyse The Market From A Different Angle